Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 157

Similar articles for PubMed (Select 19704170)

1.

Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007.

Hurt CB, McCoy SI, Kuruc J, Nelson JA, Kerkau M, Fiscus S, McGee K, Sebastian J, Leone P, Pilcher C, Hicks C, Eron J.

Antivir Ther. 2009;14(5):673-8.

2.

Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic.

Kleyn TJ, Liedtke MD, Harrison DL, Lockhart SM, Salvaggio MR, Ripley TL, Rathbun RC.

Ann Pharmacother. 2014 Apr;48(4):470-5. doi: 10.1177/1060028013519246. Epub 2014 Jan 28.

PMID:
24473489
3.

Prevalence and patterns of HIV transmitted drug resistance in Guatemala.

Avila-Ríos S, Mejía-Villatoro CR, García-Morales C, Soto-Nava M, Escobar I, Mendizabal R, Girón A, García L, Reyes-Terán G.

Rev Panam Salud Publica. 2011 Dec;30(6):641-8.

4.

HIV transmitted drug resistance in adult and pediatric populations in Panama.

Castillo J, Arteaga G, Mendoza Y, Martínez AA, Samaniego R, Estripeaut D, Page KR, Smith RE, Sosa N, Pascale JM.

Rev Panam Salud Publica. 2011 Dec;30(6):649-56.

5.

Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.

de Mulder M, Yebra G, Martín L, Prieto L, Mellado MJ, Rojo P, Muñoz-Fernández MÁ, Jiménez de Ory S, Ramos JT, Holguín A; Madrid cohort of HIV-infected children.

J Antimicrob Chemother. 2011 Oct;66(10):2362-71. doi: 10.1093/jac/dkr305. Epub 2011 Aug 2.

6.

Profile of drug resistance mutations among HIV-1-infected Tunisian subjects failing antiretroviral therapy.

Jlizi A, Ben Ammar El Gaaied A, Slim A, Tebourski F, Ben Mamou M, Ben Chaabane T, Letaief-Omezzine A, Chakroun M, Garbouj M, Ben Rejeb S.

Arch Virol. 2008;153(6):1103-8. doi: 10.1007/s00705-008-0104-z. Epub 2008 May 16.

PMID:
18483694
7.

Low prevalence of primary HIV resistance in western Massachusetts.

Iarikov DE, Irizarry-Acosta M, Martorell C, Hoffman RP, Skiest DJ.

J Int Assoc Physicians AIDS Care (Chic). 2010 Jul-Aug;9(4):227-31. doi: 10.1177/1545109710374998.

PMID:
20798402
8.

HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.

Aulicino PC, Rocco CA, Mecikovsky D, Bologna R, Mangano A, Sen L.

Antivir Ther. 2010;15(4):641-50. doi: 10.3851/IMP1571.

PMID:
20587857
9.

Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.

Romero A, Sued O, Puig T, Esteve A, Pumarola T, Casabona J, González V, Matas L, Tural C, Rodrigo I, Margall N, Domingo P, Casanova A, Ferrer E, Caballero E, Ribera E, Farré J, Puig T, Amengual MJ, Navarro G, Prat JM, Masabeu A, Simó JM, Villaverde CA, Barrufet P, Sauca MG, Ortin X, Ortí A, Navarro R, Euras JM, Vilaró J, Villà MC, Montull S, Vilanova C, Pujol F, Díaz O, Miró JM; AERI study Group.

Enferm Infecc Microbiol Clin. 2011 Aug-Sep;29(7):482-9. doi: 10.1016/j.eimc.2011.03.001. Epub 2011 May 2.

PMID:
21543135
10.

Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for Antiretrovirals.

Violin M, Forbici F, Cozzi-Lepri A, Velleca R, Bertoli A, Riva C, Giannella S, Manconi PE, Lazzarin A, Pasquinucci S, Tacconi L, Carnevale G, Mazzotta F, Bonazzi L, Montroni M, Chirianni A, Capobianchi M, Ippolito G, Moroni M, Perno CF, D'Arminio-Monforte A; I.CO.N.A. Study Group. Italian Cohort of Antiretroviral Naive patients.

J Biol Regul Homeost Agents. 2002 Jan-Mar;16(1):37-43.

PMID:
12003172
11.

Prevalence of genotypic resistance to nucleoside analogues, nonnucleoside analogues, and protease inhibitors in HIV-infected persons in Athens, Greece.

Panos G, Charatsis G, Paparizos V, Kazantzi M, Falagas ME.

AIDS Res Hum Retroviruses. 2008 Jan;24(1):43-51. doi: 10.1089/aid.2006.0217.

PMID:
18275347
12.

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.

Hamers RL, Wallis CL, Kityo C, Siwale M, Mandaliya K, Conradie F, Botes ME, Wellington M, Osibogun A, Sigaloff KC, Nankya I, Schuurman R, Wit FW, Stevens WS, van Vugt M, de Wit TF; PharmAccess African Studies to Evaluate Resistance (PASER).

Lancet Infect Dis. 2011 Oct;11(10):750-9. doi: 10.1016/S1473-3099(11)70149-9. Epub 2011 Jul 27.

PMID:
21802367
13.

Transmitted drug resistance among antiretroviral-naive patients with established HIV type 1 infection in Santo Domingo, Dominican Republic and review of the Latin American and Caribbean literature.

Myers JE, Taylor BS, Rojas Fermín RA, Reyes EV, Vaughan C, José L, Javier C, Franco Estévez R, Donastorg Cabral Y, Batista A, Lie Y, Coakley E, Hammer SM, Brudney K.

AIDS Res Hum Retroviruses. 2012 Jul;28(7):667-74. doi: 10.1089/AID.2010.0355. Epub 2011 Sep 23. Review.

14.

Low prevalence of transmitted antiretroviral drug resistance in a large UK HIV-1 cohort.

Payne BA, Nsutebu EF, Hunter ER, Olarinde O, Collini P, Dunbar JA, Basta MS, Elston JW, Schmid ML, Thaker H, Chadwick DR.

J Antimicrob Chemother. 2008 Sep;62(3):464-8. doi: 10.1093/jac/dkn228. Epub 2008 Jun 13.

15.

Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia.

Balode D, Westman M, Kolupajeva T, Rozentale B, Albert J.

J Med Virol. 2010 Dec;82(12):2013-8. doi: 10.1002/jmv.21921.

PMID:
20981787
16.

Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries.

Aghokeng AF, Vergne L, Mpoudi-Ngole E, Mbangue M, Deoudje N, Mokondji E, Nambei WS, Peyou-Ndi MM, Moka JJ, Delaporte E, Peeters M.

Antivir Ther. 2009;14(3):401-11.

PMID:
19474474
17.

Primary drug resistance in antiretroviral-naïve injection drug users.

Tossonian HK, Raffa JD, Grebely J, Viljoen M, Mead A, Khara M, McLean M, Krishnamurthy A, DeVlaming S, Conway B.

Int J Infect Dis. 2009 Sep;13(5):577-83. doi: 10.1016/j.ijid.2008.08.028. Epub 2008 Dec 25.

18.

Low prevalence of transmitted drug resistance of HIV-1 during 2008-2012 antiretroviral therapy scaling up in Southern Vietnam.

Tanuma J, Quang VM, Hachiya A, Joya A, Watanabe K, Gatanaga H, Van Vinh Chau N, Chinh NT, Oka S.

J Acquir Immune Defic Syndr. 2014 Aug 1;66(4):358-64. doi: 10.1097/QAI.0000000000000196.

PMID:
24815852
19.

New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China.

Zhao B, Han X, Dai D, Liu J, Ding H, Xu J, Chu Z, Bice T, Diao Y, Shang H.

AIDS Res Hum Retroviruses. 2011 Oct;27(10):1047-53. doi: 10.1089/AID.2010.0119. Epub 2011 May 6.

PMID:
21417755
20.

The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco.

Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Elfilali KM, Ezzikouri S, Abidi O, Hassar M, Wakrim L.

J Infect Dev Ctries. 2009 Jun 1;3(5):380-91.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk